+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Latin America, Middle East & Africa Fractional Flow Reserve Market (2019-2025)

  • ID: 4871821
  • Report
  • November 2019
  • Region: Africa, Latin America, Middle East
  • 98 Pages
  • Marqual IT Solutions Pvt. Ltd (KBV Research)

FEATURED COMPANIES

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Bracco S.p.A. and
  • General Electric (GE) Co
  • Koninklijke Philips N.V.
  • Medtronic PLC
The LAMEA Fractional Flow Reserve Market is expected to grow at a CAGR of 11.2% during 2019 -2025. The Brazil market dominated the LAMEA Meal Replacement Products Market by Country 2018, thereby, growing at a CAGR of 6.9 % during the forecast period.

FFR facilitates the effects of a narrowed vessel to be estimated in real-time and enables simultaneous treatment with balloon dilatation and stenting. That being said, FFR is an invasive procedure for which there are non-invasive (less drastic) options, such as testing for cardiac stress. In this procedure, physical exercise or intravenous treatment is used to increase the workload and oxygen demand of the heart muscle, and ischemia is detected using ECG fluctuations or nuclear imaging.

Fractional flow reserve (FFR) is a coronary artery perfusion physiological measurement. Studies have shown its utility in reducing costs and improving outcomes for patients undergoing elective coronary angiography, although follow-up studies have shown low adoption regionally. All statistically significant predictors for FFR use are age, gender, race, previous stress testing, and the country's area.

For cases of cardiovascular diseases like coronary artery diseases and high blood pressure, an upswing has occurred, which persists to be a key factor for market growth. As per the American College of Cardiology (ACC), in 2017, nearly 31.0 percent of all deaths worldwide were caused by cardiovascular diseases.

In the year 2016, industry participants like Opsens Medical diverted net proceeds earnings towards R&D, commercialization, and marketing of its fractional flow reserve. Therefore, an increase in the research-centered investments to develop novel cost-efficient equipment is anticipated to bode well for the market.

On the contrary, market giants like B. Braun Melsungen, Medtronic plc, Siemens and Terumo Medical Corporation might come forth as potential market entrants with the product launch of allied products used for FFR. As an example, in 2019, Siemens Healthineers launched Sensis Vibe CTx. It was capable of generating the required data for CT based FFR. This initiative was under the expectation of gaining more visibility in the FFR and OCT market situation.

Based on Product, the market is segmented into FFR guidewires and FFR Monitoring Systems. Based on Application, the market is segmented into Multi-Vessel Coronary Artery Disease and Single-Vessel Coronary Artery Disease. The report also covers geographical segmentation of LAMEA Fractional Flow Reserve market. The countries included in the report are Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria and Rest of LAMEA.

Key companies profiled in the report include Medtronic PLC, Terumo Corporation, B. Braun Melsungen AG, General Electric (GE) Co, Siemens AG (Siemens Healthineers), Koninklijke Philips N.V., Boston Scientific Corporation, Abbott Laboratories, Bracco S.p.A. and Opsens, Inc.

Scope of the Study

Market Segmentation:

By Product
  • FFR guidewires and
  • FFR Monitoring Systems

By Application
  • Multi-Vessel Coronary Artery Disease and
  • Single-Vessel Coronary Artery Disease

By Country
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Companies Profiled
  • Medtronic PLC
  • Terumo Corporation
  • B. Braun Melsungen AG
  • General Electric (GE) Co
  • Siemens AG (Siemens Healthineers)
  • Koninklijke Philips N.V.
  • Boston Scientific Corporation
  • Abbott Laboratories
  • Bracco S.p.A. and
  • Opsens, Inc.

Unique Offerings from the Publisher
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Bracco S.p.A. and
  • General Electric (GE) Co
  • Koninklijke Philips N.V.
  • Medtronic PLC

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Fractional Flow Reserve Market, by Product
1.4.2 LAMEA Fractional Flow Reserve Market, by Application
1.4.3 LAMEA Fractional Flow Reserve Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
Chapter 3. Market Analysis
3.1 Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches
3.2.3 Expansions
3.2.4 Mergers & Acquisitions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2015-2019)
3.3.2 Key Strategic Move: (Collaborations, Partnerships, and Agreements : 2019-Oct - 2016-Aug) Leading Players
Chapter 4. LAMEA Fractional Flow Reserve Market by Product
4.1 LAMEA FFR guidewires Market by Country
4.2 LAMEA FFR Monitoring Systems Market by Country
Chapter 5. LAMEA Fractional Flow Reserve Market by Application
5.1 LAMEA Multi-Vessel Coronary Artery Disease Market by Country
5.2 LAMEA Single-Vessel Coronary Artery Disease Market by Country
Chapter 6. LAMEA Fractional Flow Reserve Market by Country
6.1 Brazil Fractional Flow Reserve Market
6.1.1 Brazil Fractional Flow Reserve Market by Product
6.1.2 Brazil Fractional Flow Reserve Market by Application
6.2 Argentina Fractional Flow Reserve Market
6.2.1 Argentina Fractional Flow Reserve Market by Product
6.2.2 Argentina Fractional Flow Reserve Market by Application
6.3 UAE Fractional Flow Reserve Market
6.3.1 UAE Fractional Flow Reserve Market by Product
6.3.2 UAE Fractional Flow Reserve Market by Application
6.4 Saudi Arabia Fractional Flow Reserve Market
6.4.1 Saudi Arabia Fractional Flow Reserve Market by Product
6.4.2 Saudi Arabia Fractional Flow Reserve Market by Application
6.5 South Africa Fractional Flow Reserve Market
6.5.1 South Africa Fractional Flow Reserve Market by Product
6.5.2 South Africa Fractional Flow Reserve Market by Application
6.6 Nigeria Fractional Flow Reserve Market
6.6.1 Nigeria Fractional Flow Reserve Market by Product
6.6.2 Nigeria Fractional Flow Reserve Market by Application
6.7 Rest of LAMEA Fractional Flow Reserve Market
6.7.1 Rest of LAMEA Fractional Flow Reserve Market by Product
6.7.2 Rest of LAMEA Fractional Flow Reserve Market by Application
Chapter 7. Company Profiles
7.1 Medtronic PLC
7.1.1 Company overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expenses
7.1.5 Recent strategies and developments
7.1.5.1 Acquisition and Mergers
7.1.5.2 Product Launches
7.1.6 SWOT Analysis
7.2 Terumo Corporation
7.2.1 Company Overview
7.2.1 Financial Analysis
7.2.2 Segmental Analysis
7.2.3 Recent strategies and developments
7.2.3.1 Collaborations, Partnerships, and Agreements
7.2.3.2 Acquisition and Mergers
7.3 B. Braun Melsungen AG
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.3.5 Recent strategies and developments
7.3.5.1 Collaborations, Partnerships, and Agreements
7.4 General Electric (GE) Co.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.4.5 Recent strategies and developments
7.4.5.1 Collaborations, Partnerships, and Agreements
7.4.6 SWOT Analysis
7.5 Siemens AG (Siemens Healthineers)
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments
7.5.5.1 Collaborations, Partnerships, and Agreements
7.5.6 SWOT Analysis
7.6 Koninklijke Philips N.V.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expenses
7.6.5 Recent strategies and developments
7.6.5.1 Collaborations, Partnerships, and Agreements
7.6.5.2 Acquisition and Mergers
7.6.5.3 Product Launches
7.6.6 SWOT Analysis
7.7 Boston Scientific Corporation
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.7.5 Recent strategies and developments
7.7.5.1 Expansions
7.7.6 SWOT Analysis
7.8 Abbott Laboratories
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.8.5 Recent strategies and developments
7.8.5.1 Acquisition and Mergers
7.8.5.2 Product Launches
7.8.6 SWOT Analysis
7.9 Bracco S.p.A.
7.9.1 Company Overview
7.9.2 Regional Analysis
7.1 Opsens, Inc.
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expense
7.10.5 Recent strategies and developments
7.10.5.1 Collaborations, Partnerships, and Agreements
Note: Product cover images may vary from those shown
  • Medtronic PLC
  • Terumo Corporation
  • B. Braun Melsungen AG
  • General Electric (GE) Co
  • Siemens AG (Siemens Healthineers)
  • Koninklijke Philips N.V.
  • Boston Scientific Corporation
  • Abbott Laboratories
  • Bracco S.p.A. and
  • Opsens, Inc.
Note: Product cover images may vary from those shown

Loading
LOADING...